Silver Book Fact

The greater use of medications and revascularization would provide approximately a 17% reduction in 2 year mortality combined.

Rosen, Allison B., David M. Cutler, Douglas M. Norton, Hsou Mei Hu, and Sandeep Vijan. The Value Of Coronary Heart Disease Care For The Elderly: 1987-2002. Health Affairs. 2007; 26(1): 111-123

Reference

Title
The Value Of Coronary Heart Disease Care For The Elderly: 1987-2002
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Rosen, Allison B., David M. Cutler, Douglas M. Norton, Hsou Mei Hu, and Sandeep Vijan
Volume & Issue
Volume 26, Issue 1
Pages
111-123

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Every additional dollar spent on the routine use of beta-blockers (versus under-use) in acute heart attack patients has produced health gains valued as high as $38.44.  
  • Increased use of non-acute medications in primary and secondary prevention explains about 1/3 of the total reduction in cardiovascular disease mortality since 1950.  
  • Increased use of a blood-thinning drug saves $600 million annually, because of the strokes it prevents.  
  • “Sherri Selph was 41 when she was first diagnosed with second-stage congestive heart failure. However, her rapidly diminishing health led to a diagnosis of end-stage heart disease. A heart transplant…  
  • Aspirin, beta-blockers, angiotensin-converting enzyme inhibitors, and statins, when taken in combination, have been estimated to reduce the relative risk of coronary heart disease mortality by 80%, compared with a placebo.